123 related articles for article (PubMed ID: 14727630)
1. NSAIDS and esophageal cancer.
Scherübl H; Sutter AP; Zeitz M
Gastroenterology; 2003 Dec; 125(6):1914-5; author reply 1915. PubMed ID: 14727630
[No Abstract] [Full Text] [Related]
2. Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis.
Corley DA; Kerlikowske K; Verma R; Buffler P
Gastroenterology; 2003 Jan; 124(1):47-56. PubMed ID: 12512029
[TBL] [Abstract][Full Text] [Related]
3. Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer.
Farrow DC; Vaughan TL; Hansten PD; Stanford JL; Risch HA; Gammon MD; Chow WH; Dubrow R; Ahsan H; Mayne ST; Schoenberg JB; West AB; Rotterdam H; Fraumeni JF; Blot WJ
Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):97-102. PubMed ID: 9488582
[TBL] [Abstract][Full Text] [Related]
4. Aspirin and esophageal squamous cell carcinoma: bedside to bench.
Li P; Cheng R; Zhang S
Chin Med J (Engl); 2014; 127(7):1365-9. PubMed ID: 24709195
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis: non-steroidal anti-inflammatory drug use and the risk of esophageal squamous cell carcinoma.
Sun L; Yu S
Dis Esophagus; 2011 Nov; 24(8):544-9. PubMed ID: 21539676
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers identified to predict esophageal cancer susceptibility and aspirin found to lower cancer risk.
Future Oncol; 2007 Apr; 3(2):127. PubMed ID: 17381411
[No Abstract] [Full Text] [Related]
7. Gastro-oesophageal reflux symptoms and the risks of oesophageal cancer: are the effects modified by smoking, NSAIDs or acid suppressants?
Pandeya N; Webb PM; Sadeghi S; Green AC; Whiteman DC;
Gut; 2010 Jan; 59(1):31-8. PubMed ID: 19875392
[TBL] [Abstract][Full Text] [Related]
8. Nonsteroidal anti-inflammatory drugs and esophageal inflammation - Barrett's esophagus - adenocarcinoma sequence: a meta-analysis.
Wang F; Lv ZS; Fu YK
Dis Esophagus; 2011 Jul; 24(5):318-24. PubMed ID: 21166737
[TBL] [Abstract][Full Text] [Related]
9. Aspirin, NSAIDS and human cancer.
Hill MJ
Eur J Cancer Prev; 1996 Aug; 5(4):219-20. PubMed ID: 8894558
[No Abstract] [Full Text] [Related]
10. COX-2: a target for prevention and treatment of esophageal cancer.
Altorki N
J Surg Res; 2004 Mar; 117(1):114-20. PubMed ID: 15013721
[No Abstract] [Full Text] [Related]
11. Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis.
Abnet CC; Freedman ND; Kamangar F; Leitzmann MF; Hollenbeck AR; Schatzkin A
Br J Cancer; 2009 Feb; 100(3):551-7. PubMed ID: 19156150
[TBL] [Abstract][Full Text] [Related]
12. NSAIDs, Barrett's oesophagus and adenocarcinoma prevention.
Vainio H; Morgan G
Eur J Cancer Prev; 1997 Apr; 6(2):200. PubMed ID: 9237071
[No Abstract] [Full Text] [Related]
13. Regular aspirin use and esophageal cancer risk.
Jayaprakash V; Menezes RJ; Javle MM; McCann SE; Baker JA; Reid ME; Natarajan N; Moysich KB
Int J Cancer; 2006 Jul; 119(1):202-7. PubMed ID: 16450404
[TBL] [Abstract][Full Text] [Related]
14. NSAIDs and the chemoprevention of colon and oesophageal cancer.
Morgan GP
Gut; 1995 Jan; 36(1):153-4. PubMed ID: 7890226
[No Abstract] [Full Text] [Related]
15. Aspirin and nonsteroidal anti-inflammatory drugs can prevent cutaneous squamous cell carcinoma: a systematic review and meta-analysis.
Muranushi C; Olsen CM; Pandeya N; Green AC
J Invest Dermatol; 2015 Apr; 135(4):975-983. PubMed ID: 25521453
[TBL] [Abstract][Full Text] [Related]
16. Aspirin and reduced risk of esophageal carcinoma.
Funkhouser EM; Sharp GB
Cancer; 1995 Oct; 76(7):1116-9. PubMed ID: 8630885
[TBL] [Abstract][Full Text] [Related]
17. Chemoprevention of lung cancer by non-steroidal anti-inflammatory drugs among cigarette smokers.
Harris RE; Beebe-Donk J; Schuller HM
Oncol Rep; 2002; 9(4):693-5. PubMed ID: 12066194
[TBL] [Abstract][Full Text] [Related]
18. Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequence.
Anderson LA; Johnston BT; Watson RG; Murphy SJ; Ferguson HR; Comber H; McGuigan J; Reynolds JV; Murray LJ
Cancer Res; 2006 May; 66(9):4975-82. PubMed ID: 16651456
[TBL] [Abstract][Full Text] [Related]
19. [Medical treatment of Barrett's esophagus].
Kinoshita Y; Yuki T
Nihon Rinsho; 2005 Aug; 63(8):1449-53. PubMed ID: 16101238
[TBL] [Abstract][Full Text] [Related]
20. Daily use of non-steroidal anti-inflammatory drugs is less frequent in patients with Barrett's oesophagus who develop an oesophageal adenocarcinoma.
Tsibouris P; Hendrickse MT; Isaacs PE
Aliment Pharmacol Ther; 2004 Sep; 20(6):645-55. PubMed ID: 15352913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
